Feasibility and Safety Evaluation of Endoscopic Treatment of Esophagogastric Varices in Cirrhosis… (NCT07129447) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Feasibility and Safety Evaluation of Endoscopic Treatment of Esophagogastric Varices in Cirrhosis on the Day-care Unit
330 participantsStarted 2025-09-01
Plain-language summary
The goal of this observational study is to learn about the feasibility and safety evaluation of endoscopic treatment of esophagogastric varices in cirrhosis on the day-care ward. The main question it aims to answer is:
Is inpatient endoscopic treatment on day wards also feasible and safe for patients with esophagogastric variceal bleeding in cirrhosis when compared to inpatient endoscopy on a general ward? Participants undergoing inpatient endoscopic treatment for cirrhotic esophagogastric variceal bleeding on day wards and general wards will answer online survey questions about their postoperative period over a 1-year period.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. aged 18-75 years;
✓. diagnosis of cirrhosis and portal hypertension by clinical manifestations, laboratory tests, imaging tests and histologic examinations;
✓. gastroscopic grading of esophagogastric varices as moderate or severe;
✓. no ruptured esophagogastric varices bleeding in the last 5 days;
✓. endoscopic treatment of esophagogastric varices during hospitalization.
Exclusion criteria
✕. first endoscopic treatment of esophagogastric varices;
✕. this is an acute esophagogastric variceal rupture and bleeding;
✕. previous TIPS or liver transplantation;
✕. isolated fundal varices or ectopic varices;
✕. primary hepatocellular carcinoma or acute or chronic hepatic failure, Child-pugh class C, hepatic encephalopathy stage 2 or higher;
What they're measuring
1
Variceal rebleeding rate at 1-year follow-up after enrollment